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Abstract: PURPOSE Lemierre syndrome is a life-threatening condition characterized by head/neck bac-
terial infection, local suppurative thrombophlebitis and septic embolic complications in a range of sites of
distant organs. No prior study focused on the course and characteristics of ophthalmic complications of
Lemierre syndrome. METHODS We analysed data of 27 patients with ophthalmic complications from a
large cohort of 712 cases with Lemierre syndrome reported globally between 2000 and 2017. We focused
on initial manifestations, early (in-hospital) course and long-term ophthalmic deficits at the time of hos-
pital discharge or during postdischarge follow-up. The study protocol was registered in the International
Prospective Register of Systematic Reviews PROSPERO (CRD42016052572). RESULTS Nine (33%)
patients were women; the median age was 20 (Q1-Q3: 15-33) years. Fusobacterium spp. was involved
in 56% of cases. The most prevalent initial manifestations were decreased vision (35%) and periocular
oedema (38%), followed by impaired eye movements/nerve palsy (28%) and proptosis (28%). Venous
involvement, notably cerebral vein thrombosis (70%) and ophthalmic vein thrombosis (55%), explained
the symptomatology in most cases. Septic embolism (7%), orbital abscesses (2%) and carotid stenosis
(14%) were also present. Ophthalmic sequelae were reported in 9 (33%) patients, often consisting of
blindness or reduced visual acuity, and nerve paralysis/paresis. CONCLUSION Ophthalmic complica-
tions represent a severe manifestation of Lemierre syndrome, often reflecting an underlying cerebral vein
thrombosis. Visual acuity loss and long-term severe complications are frequent. We call for an interdis-
ciplinary approach to the management of patients with Lemierre syndrome and the routine involvement
of ophthalmologists.
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ABSTRACT.
Purpose: Lemierre syndrome is a life-threatening condition characterized by
head/neck bacterial infection, local suppurative thrombophlebitis and septic embolic
complications in a range of sites of distant organs. No prior study focused on the
course and characteristics of ophthalmic complications of Lemierre syndrome.
Methods: We analysed data of 27 patients with ophthalmic complications from
a large cohort of 712 cases with Lemierre syndrome reported globally between
2000 and 2017. We focused on initial manifestations, early (in-hospital) course
and long-term ophthalmic deficits at the time of hospital discharge or during
postdischarge follow-up. The study protocol was registered in the International
Prospective Register of Systematic Reviews PROSPERO (CRD42016052572).
Results: Nine(33%)patientswerewomen;themedianagewas20(Q1–Q3:15–33)years.
Fusobacteriumspp.wasinvolvedin56%ofcases.Themostprevalentinitialmanifestations
were decreased vision (35%) and periocular oedema (38%), followed by impaired eye
movements/nervepalsy(28%)andproptosis(28%).Venousinvolvement,notablycerebral
vein thrombosis (70%)andophthalmic vein thrombosis (55%), explained the symptoma-
tology in most cases. Septic embolism (7%), orbital abscesses (2%) and carotid stenosis
(14%) were also present. Ophthalmic sequelae were reported in 9 (33%) patients, often
consisting of blindness or reduced visual acuity, and nerve paralysis/paresis.
Conclusion: Ophthalmic complications represent a severe manifestation of
Lemierre syndrome, often reflecting an underlying cerebral vein thrombosis.
Visual acuity loss and long-term severe complications are frequent. We call for
an interdisciplinary approach to the management of patients with Lemierre
syndrome and the routine involvement of ophthalmologists.
Key words: anticoagulation – bacterial infection – lemierre syndrome – mycotic aneurysm – oc-
ular vein thrombosis – rare disorders
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a severe manifestation of Lemierre
syndrome, often reflecting an under-
lying cerebral vein thrombosis.
Visual acuity loss and long-term
severe complications are frequent,
calling for an interdisciplinary man-
agement of patients with Lemierre
syndrome.
Introduction
Lemierre syndrome is a life-threatening
condition characterized by head/neck
bacterial infection, local suppurative
thrombophlebitis and septic embolic
complications in a range of sites of
distant organs, primarily the lungs. The
disorder represents the most feared
complications of bacterial tonsillitis
and neck infections (Lemierre 1936;
Sacco et al. 2019; Valerio et al., 2020a,
2020b). The bacterium most frequently
involved is Fusobacterium necropho-
rum, a gram-negative anaerobe that is
highly prevalent in the oropharynx of
healthy subjects and can be isolated in
patients with acute tonsillitis or peri-
tonsillar abscess (Klug et al. 2011;
Centor et al. 2015; Atkinson et al.
2018; Nygren & Holm 2019).
As in other thromboembolic condi-
tions, such as infective endocarditis and
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atrial fibrillation, the eyes represent a
potential site of embolization. A recent
study showed that up to 9% of patients
with ischaemic monocular blindness had
atrial fibrillation, which caused a tran-
sient or permanent occlusion of the
central or branch retinal artery (Baddour
et al. 2015; Zarkali et al. 2019). Data on
the associationbetween neckvein throm-
bosis or cerebral vein thrombosis and
ophthalmic involvement are sparse, but
indicates that ophthalmic complications
are not uncommon (Wang et al. 2011;
Yadegari et al. 2017). Lemierre syn-
drome may cause a wide range of oph-
thalmic complications and share some
similaritieswith the aforementioned con-
ditions. Its potential for local throm-
boembolic dissemination, the occurrence
of both venous and arterial complica-
tions, and the presence of a strong
bacterial trigger suggest that ophthalmic
involvement in Lemierre syndrome may
present peculiar features.
Recently, we published the largest
individual patient level analysis of
Lemierre syndrome cases, amounting
to a total of 712 patients which gave an
overview of the course of the disease in
the contemporary era (2000–2017) and
contributed to define the clinical and
epidemiological characteristics of the
syndrome (Valerio et al., 2020a,
2020b). In the present analysis, we
provided a comprehensive analysis of
the prevalence, characteristics and
course of ophthalmic complications in
patients with Lemierre syndrome.
Patients and Methods
Data collection
We previously described the procedures
of data collection, assessment of outcome
variables, and analysis that were imple-
mented for this study (Sacco et al. 2019).
In brief, we searched all studies reporting
cases or series of cases of Lemierre
syndrome published in the biomedical
or ‘grey’ literature in 2000–2017. The
authors of these reports were contacted
to retrieve individual level data or missing
information. The study protocol is regis-
tered in the International Prospective
Register of Systematic Reviews PROS-
PERO (CRD42016052572).
This study was conducted as an
individual level analysis of patients diag-
nosed with Lemierre syndrome and
aimed to describe the characteristics
and course of those with ophthalmic
complications or symptoms. Cases were
considered eligible for inclusion if the
diagnosis of Lemierre syndrome was
based on the following criteria (Valerio
et al., 2020a, 2020b): the primary bacte-
rial infection affected the head/neck,
local thrombotic complications or septic
embolism were objectively confirmed,
and any ophthalmic involvement or eye-
related symptom was described.
We focused on two main triggers of
ophthalmic complications or symptoms
present at baseline or detected during
initial hospitalization: (i) objectivelydiag-
nosed acute venous thromboembolism
or/and septic embolism, (ii) supra-aortic
arterial stenosis/occlusion or mycotic
aneurysms. We also collected data on
in-hospital death and long-term oph-
thalmic complications after hospital dis-
charge. Venous thromboembolism or/
and septic embolism included cerebral
vein thrombosis, neck vein thrombosis,
ophthalmic vein thrombosis (OVT) and
other venous thrombosis localized in the
head/neck region which may have been
involved in ophthalmic symptoms.
Involvement of supra-aortic arteries
included neck artery stenosis or occlusion
of the carotid arteries, vertebral arteries
or intracranial arteries. Thrombosis was
only considered as such if it was objec-
tively confirmed in a radiology report.
For each patient, we noted informa-
tion on demographics, baseline charac-
teristics, site of initial infection,
characteristics of initial clinical presenta-
tion, use and type of antibiotics, use and
type of anticoagulation, surgical proce-
dures and clinical/ophthalmic outcome.
The complete database and variable cod-
ing list are available upon request by
directly contacting the authors.
Statistical analysis
We provided categorical variables as
counts and percentages with corre-
sponding 95% confidence intervals
(CI) for the outcomes of interest and
continuous variables as median and
interquartile range (Q1–Q3) or as mean
and standard deviation, according to
their distribution. In this descriptive
analysis, we refrained from performing
explorative analyses on potential risk
factors of ophthalmic complications
due to the anticipated low number of
events and lack of literature data to
support the choice of the predictors.
Data management was done in SPSS,
version 25.0 (SPSS Inc. Chicago,
Illinois). Data analysis was conducted
with R version 3.6.1 (The R Founda-
tion for Statistical Computing, 2019).
Results
Of 712 patients with Lemierre syndrome
included in the overall cohort, we found
27 (3.8%) who presented with or were
described having ophthalmic complica-
tions or related symptoms (Benhayoun
et al. 2003; Figueras Nadal et al. 2003;
Ahad et al. 2004; Arat et al. 2004;
Bentham et al. 2004; Peng et al. 2005;
Olson & Mandava 2006; Westhout
2007; Kadhiravan et al. 2008; Shiva-
shankar et al. 2008; van Dijk et al. 2008;
Jones & Arnold 2009; Aouad et al.
2010; Bababeygy et al. 2011; Kahn
2011; Miller et al. 2012; Rehman 2012;
Akiyama et al. 2013; Gutzeit et al. 2013;
Stauffer 2013; Creemers-Schild 2014;
Golan et al. 2014; Garibova 2015; Holm
et al. 2015; Nishida et al. 2015; Ballester
et al. 2016; Hama et al. 2016). Nine
(33%) patients were women and the
median age was 20 (Q1–Q3 15–33)
years. The most frequent site of initial
bacterial infection was the oropharynx
(44%) or the neck/head (33%). Fusobac-
terium spp. was involved in 56% of
cases. All patients had neck vein throm-
bosis: internal jugular vein thrombosis
was present in 21 (78%) cases and
cerebral vein thrombosis was diagnosed
in 19 (70%). Table 1 summarizes the
key demographic and baseline charac-
teristics of the study population.
All patients received antibiotic ther-
apy, which consisted of penicillins
(41%), metronidazole (33%), clin-
damycin (9%), cephalosporins (56%)
and carbapenems (33%) in most cases.
Twenty (74%) patients underwent sur-
gical procedures, such as abscess drai-
nage (63%) and craniectomy or
craniotomy (22%). Any-dosage antico-
agulant use was recorded in the vast
majority (85%) of patients.
Ophthalmic complications
The majority (63%) of complications
were already present at the time of initial
admission. Table 2 details the character-
istics and outcome of ophthalmic com-
plications on an individual patient level.
As depicted in Table 3, the most preva-
lent signs and symptoms were decreased
vision (35%) and periocular oedema or
eye swelling (38%), followed by impaired
eye movements/nerve palsy (28%) and
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proptosis (28%). The most frequent
diagnoses explaining the ophthalmic
complications were cerebral vein throm-
bosis (70%) and superior OVT (55%).
Septic embolism (7%), orbital abscesses
(2%) and carotid stenosis (14%)
explained the symptoms in the remaining
patients. Three patients had concomitant
arterial and venous complications. Three
patients (11%) had some type of intraoc-
ular bleeding, including (i) haemorrhages
in the right eye fundus (off anticoagu-
lant), (ii) vitreous haemorrhage in the
right eyeandpreretinalbleeding in the left
eye (off anticoagulant) and (iii) preretinal
haemorrhage in fovea (onanticoagulant).
Two patients died during hospital-
ization due to sepsis and multiorgan
failure. Long-term complications
included blindness or reduced visual
acuity in 7 (26%) patients and abnor-
mal eye movements or cranial nerve
palsies in 6 (21%) (Table 2).
Discussion
This study represents the largest anal-
ysis of ophthalmic complications of
Lemierre syndrome, a rare and poten-
tially fatal thromboembolic complica-
tion of bacterial pharyngotonsillitis in
otherwise healthy teenagers and young
adults. We showed that venous com-
plications, usually represented by neck
vein thrombosis leading to cerebral
vein thrombosis and OVT, dominate
the clinical picture and explain oph-
thalmic manifestations in the vast
majority of patients. Our data also
indicate that long-term complications
are potentially invalidating and may
include reduced visual acuity, paraly-
sis/paresis and cranial nerve palsies.
Lemierre syndrome represents a severe
condition with a broad spectrum of
complications that go beyond early in-
hospital death: the presence of oph-
thalmic involvement may represent a
signal of cerebral vein involvement
requiring rapid action.
Superior OVT may result from ret-
rograde extension of cavernous sinus
thrombosis (which, in turn, is involved
via the inferior petrosal sinus from a
primary thrombophlebitis of the jugu-
lar vein or the lateral sinus) or, in cases
with paranasal sinusitis or odontogenic
infection as the primary focus, orbital
inflammation and cellulitis (van der
Poel et al. 2019). Less common mech-
anisms may include a systemically
hypercoagulable state induced by sepsis
(Valerio & Riva 2020) or haematoge-
nous spread of bacteria from a distant
focus with septic embolization (Hajar
et al. 2019). Superior OVT impairs
local venous drainage and leads to
orbital congestion, which ultimately
causes orbital manifestations including
chemosis, proptosis, diplopia and pain
(van der Poel et al. 2019). In this
context, ocular pain is probably multi-
factorial. The most direct causes are
local swelling and inflammation.
Venous stasis can lead to increased
pressure in the eye and the surrounding
structures. Overall increased intracra-
nial pressure could lead to headache
that the patient may experience as
retro-ocular pain. Last, orbital pain is
common in sinusitis, one of the possi-
ble primary infections in Lemierre
syndrome. The spectrum of clinical
findings can extend to ocular signs
and symptoms, including reduced
visual acuity and relative afferent
pupillary defect, if the optic nerve is
affected by compression and an optic
neuropathy is diagnosed (Lim et al.
2014). A key finding of our study is the
description of cavernous sinus throm-
bosis in association with superior OVT,
which was diagnosed in four patients
and was bilateral in one case. Lateral
rectus paralysis due to abducens nerve
palsy is one of the most frequently
observed symptoms in these patients.
The presence of abducens nerve palsy is
likely to be most often associated with
cavernous sinus thrombosis, and more
rarely inflammatory swelling of the
rectus lateral muscle or orbital celluli-
tis. Of note, it must be recognized that
no standard definition and validated
diagnostic work-up of superior (septic)
OVT and OV dilation are available to
date: the same applies to other rare
localizations of vein thrombosis,
including splanchnic or ovarian vein
thrombosis.
The prevalence of any cerebral vein
thrombosis was remarkable (70%) in
patients with ophthalmic complications
of Lemierre syndrome and much higher
than that (20%) described in the whole
cohort of 712 patients with Lemierre
syndrome (Valerio et al., 2020a,2020b).
Our data suggest, therefore, that if
Table 1. Baseline characteristics of 27 patients with Lemierre syndrome and ophthalmic
manifestations.
Variable Number
Women, n (%) 9 (33)
Age (years), median (Q1–Q3, range) 20 (15–53; 3–65)





Low-respiratory tract 5 (19)
Ear 3 (11)
Skin 1 (4)
Isolation of an anaerobe 20 (74)
Isolation of Fusobacterium spp 15 (56)
Arterial involvement (baseline) 5 (19)
Carotid arteries 4 (15)
Intracranial arteries 3 (11)
Venous thrombosis of the head-neck-arm district (baseline) 27 (100)
Jugular vein thrombosis 21 (78)
Peripheral embolism (baseline) 25 (93)
Lungs 18 (67)
Central nervous system 10 (37)
Surgical procedures 20 (74)
Abscess drainage (any) 17 (63)
Craniectomy/craniotomy/sinusoplasty 6 (22)
Tonsillar drainage 4 (15)
Epidural drainage 2 (7)
Jugular ligation 1 (4)
Anticoagulant used during hospitalization 17 (85)*
The key demographic and baseline characteristics of patients with ophthalmic complications in
Lemierre syndrome, including the initial site of infection, the pathogenic organisms involved and
the type of medical/surgical treatment performed.























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(mild) ophthalmic manifestations are
present, physicians should immediately
exclude the presence of cerebral vein/
septic involvement to prevent poten-
tially devastating early and late com-
plications. Prior reports demonstrated
that ophthalmic signs and symptoms
may be the initial manifestation of
cerebral vein thrombosis (Wang et al.
2011; Yadegari et al. 2017). Indeed,
intracranial involvement emerged as a
key prognostic factor associated with
poorer prognosis in patients with
Lemierre syndrome (Valerio et al.,
2020a,2020b). No specific treatment
has an established role in treating and
preventing further complications of
(septic) cerebral vein thrombosis. The
role of anticoagulant therapy in
Lemierre syndrome has long been a
matter of controversy. Its use is meant
to prevent thrombus extension or
recurrence, and is often recommended
in the case of intracerebral extension,
in analogy with observations in
patients with lateral sinus thrombosis
(Valerio & Riva 2020). However, the
possibility of haemorrhagic transfor-
mation of peripheral septic lesions or
the bleeding risk from sepsis-associated
thrombocytopenia often deter clini-
cians from its use, despite no evidence
of an intrinsically raised bleeding risk
in Lemierre syndrome (Valerio et al.,
2020a,2020b). In patients with cerebral
vein thrombosis, the use of anticoagu-
lant therapy appears reasonable based
on current evidence (Dentali et al.
2012).
Endogenous endophthalmitis was
described in two cases only. Due to
the pathophysiological characteristics
of Lemierre syndrome, it may be pos-
sible that the actual rate of septic
emboli is higher. In case of ophthalmic
artery involvement due to sepsis,
endogenous endophthalmitis may
occur and worsen the ocular symptoms
(chemosis, Best Corrected Visual Acu-
ity decrease): therefore, in the presence
of worsening of the ocular symptoms,
an endogenous endophthalmitis should
be promptly ruled out. While this
complication is rare, its possibility
implies that the rate of ophthalmic
complications in patients with
Lemierre syndrome might be even
higher if these patients underwent stan-
dard ophthalmologic assessment even
in the absence of ophthalmic symptoms
or visible ophthalmic findings like
chemosis, swelling and proptosis.
Our study has limitations, including
the relative small sample size, the lack
of a predefined assessment of oph-
thalmic signs or symptoms, the high
risk of reporting bias, and the lack of
complete information of specific diag-
nostic testing. Nonetheless, it repre-
sents the first, necessary step to
highlight the importance of a correct
multidisciplinary evaluation of patients
with Lemierre syndrome, including
distant organ and potentially silent
manifestations of disease. This likely
represents and group of patients with
the most severe ophthalmic complica-
tions of Lemierre syndrome, suggesting
that the number of those with milder
manifestations could be much larger.
Despite the young age of these
patients and the lack of severe comor-
bidities, ophthalmic complications
manifested as a severe condition often
characterized by visual acuity loss and
substantial burden of symptoms. In-
hospital death and major ophthalmic
and neurologic sequelae affected
approximately one-third of patients,
supporting the need for an early identi-
fication and management of these
potentially invalidating complications.
We call for an interdisciplinary
approach to themanagement of patients
with Lemierre syndrome and the routine
involvement of ophthalmologists.
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